Paying attention to the cerebrovascular system in glaucoma

Canadian Journal of Ophthalmology

Volumn 43, Issue 3, 2008, Pages 342-346

  Yücel, Yeni H ^a,b   Gupta, Neeru ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Cerebral blood flow; Comorbid; Ischemia; Ocular blood flow; Small vessel disease; Stroke; Vascular disease

Indexed keywords

AGING; BRAIN BLOOD VESSEL; CEREBROVASCULAR DISEASE; COMORBIDITY; DISEASE PREDISPOSITION; EYE INJURY; GLAUCOMA; HIGH RISK POPULATION; HUMAN; ISCHEMIC OPTIC NEUROPATHY; NERVE CELL LESION; OCULAR BLOOD VESSEL; OCULAR ISCHEMIC SYNDROME; REPERFUSION INJURY; REVIEW; RISK FACTOR; VISION; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; VISUAL SYSTEM; BRAIN; BRAIN CIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

BRAIN; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; GLAUCOMA; HUMANS; VISUAL PATHWAYS;

EID: 47549087740     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1139/I08-059     Document Type: Review

References (46)

1. Yücel YH, Zhang O, Gupta N, Kaufman PL, Weinreb RN. Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol 2000;118:378-84.
2. Yücel YH, Zhang O, Weinreb RN, Kaufman PL, Gupta N. Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma. Invest Ophthalmol Vis Sci 2001;42:3216-22.
3. Yücel YH, Zhang O, Weinreb RN, Kaufman PL, Gupta N. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res 2003;22:465-81.
4. Weber AJ, Chen H, Hybbard WC, Kaufman PL. Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus. Invest Ophthalmol Vis Sci 2000;41:1370-9.
5. Gupta N, Ang LC, Noël de Tilly L, Bidaisee L, Yücel YH. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 2006;90:674-8.
6. Luthra A, Gupta A, Kaufman PL, Weinreb RN, Yücel YH. Oxidative injury by peroxynitrite in neural and vascular tissue of the lateral geniculate nucleus in experimental glaucoma. Exp Eye Res 2005;80:43-9.
7. Duncan RO, Sample PA, Weinreb RN, Bowd C, Zangwill LM. Retinotopic organization of primary visual cortex in glaucoma: Comparing fMRI measurements of cortical function with visual field loss. Prog Retin Eye Res 2007;26:38-56.
8. Scremin OU. Cerebral vascular system. In: Paxinos G, Mai JK, eds. The Human Nervous System. San Diego, Calif.: Elsevier Academic Press; 2004:1325-48.
9. Ferrer I, Kaste M, Kalimo H. Vascular Diseases. In: Love S, Louis DN, Ellison DW, eds. Greenfield's Neuropathology. London, U.K.: Edward Arnold Publishers; 2008:121-240.
10. Trobe JD. The Neurology of Vision (Contemporary Neurology Series). New York, N.Y.: Oxford University Press; 2001:5-42.
11. Auer RN, Dunn JF, Sutherland GR. Hypoxia and related conditions. In: Love S, Louis DN, Ellison DW, eds. Greenfield's Neuropathology. London, U.K.: Edward Arnold Publishers; 2008:63-119.
12. Enzinger C, Smith S, Fazekas F, et al. Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study. J Neurol 2006;253:1064-70.
13. Peppiatt CM, Howarth C, Mobbs P, Attwell D. Bidirectional control of CNS capillary diameter by pericytes. Nature 2006;443:700-4.
14. Pantoni L, Garcia LH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-9.
15. Schmidt R, Scheltens P, Erkinjuntti T, et al. White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology 2004;63:139-44.
16. Bryan RN, Wells SW, Miller TJ, et al. Infarct-like lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly - data from the Cardiovascular Health Study. Radiology 1997;202:47-54.
17. de Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001;70:9-14.
18. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246-52.
19. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-41.
20. Pantoni L, Poggesi A, Inzitari D. The relation between white-matter lesions and cognition. Curr Opin Neurol 2007;2:390-7.
21. de Leeuw FE, de Groot JC, Oudkerk M, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002;125:765-72.
22. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-34.
23. Robbins J, Redline S, Ervin A, Walsleben JA, Ding J, Nieto FJ. Associations of sleep-disordered breathing and cerebral changes on MRI. J Clin Sleep Med 2005;1:159-65.
24. Vermeer SE, Hollender M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126-9.
25. Kuller LH, Lopez OL, Jagust WJ, et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology 2005;64:1548-52.
26. van Dijk EJ, Vermeer SE, de Groot JC, et al. Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatry 2004;75:733-6.
27. Hassan A, Hunt BJ, O'Sullivan M, et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004;127:212-9.
28. Hassan A, Gormley K, O'Sullivan M, et al. Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 2004;35:654-9.
29. Gormley K, Bevan S, Hassan A, Markus HS. Polymorphisms in genes of the endothelin system and cerebral small-vessel disease. Stroke 2005;36:1656-60.
30. Lammie GA. Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002;12:358-70.
31. Räihä I, Tarvonen S, Kurki T, Rajala T, Sourander I. Relationship between vascular factors and white matter low attenuation of the brain. Acta Neurol Scand 1993;87:286-9.
32. Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation 1976;53:720-7.
33. van Dijk EJ, Prins ND, Vermeer SE, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005;112:900-5.
34. Dufouil C, Chalmers J, Coskun O, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005;112:1644-50.
35. Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B; BESs Study Group. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology 2008;115:85-93.
36. Leske MC, Heijl A, Hyman L. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007;114:1965-72.
37. Drance SM. The visual field of low tension glaucoma and shock-induced optic neuropathy. Arch Ophthalmol 1977;95:1359-61.
38. Drance SM, Morgan RW, Sweeney VP. Shock-induced optic neuropathy: a cause of nonprogressive glaucoma. N Engl J Med 1973;288:392-5.
39. Gherghel D, Orgül S, Gugleta K, Flammer J. Retrobulbar blood flow in glaucoma patients with nocturnal over-dipping in systemic blood pressure. Am J Ophthalmol 2001;132:641-7.
40. Tokunaga T, Kashiwagi K, Tsumura T, Taguchi K, Tsukahara S. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma. Jpn J Ophthalmol 2004;48:380-5.
41. Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 2001;20:319-49.
42. Sergi M, Salerno DE, Rizzi M, et al. Prevalence of normal tension glaucoma in obstructive sleep apnea syndrome patients. J Glaucoma 2007;16:42-6.
43. Stroman GA, Stewart WC, Golnik KC, Curé JK, Olinger RE. Magnetic resonance imaging in patients with low-tension glaucoma. Arch Ophthalmol 1995;113:168-72.
44. Ong K, Farinelli A, Billson F, Houang M, Stern M. Comparative study of brain magnetic resonance imaging findings in patients with low-tension glaucoma and control subjects. Ophthalmology 1995;102:1632-8.
45. Sugiyama T, Utsunomiya K, Ota H, Ogura Y, Narabayashi I, Ikeda T. Comparative study of cerebral blood flow in patients with normal-tension glaucoma and control subjects. Am J Ophthalmol 2006;141:394-6.
46. Yüksel N, Anik Y, Altintaş O, Onur Y, Caǧlar Y, Demirci A. Magnetic resonance imaging of the brain in patients with pseudoexfoliation syndrome and glaucoma. Ophthalmologica 2006;220:125-30.